Researchers involved in the treatment of children infected with Ebola have developed a set of guidelines aimed at improving how Ebola-infected children are treated.
Researchers from around the world will gather April 10 to discuss the risk of emerging infectious diseases, and how best to translate research to clinical care, at the third annual conference of the Washington University Center for Global Health and Infectious Disease.
Efforts at Washington University and Barnes-Jewish and St. Louis Children’s hospitals to safely coordinate a response to the Ebola virus have been underway for several months. Among those efforts are suggested steps for faculty, staff and students traveling to and from Ebola-stricken countries.
The Ebola virus, in the midst of its biggest outbreak on record, is a master at evading the body’s immune system. But researchers at the School of Medicine and elsewhere have learned one way the virus dodges the body’s antiviral defenses, providing important insight that could lead to new therapies.
In an effort to learn why some viruses such as influenza, Ebola and West Nile are so lethal, a team of U.S. researchers plans an $18.3 million comprehensive effort to model how humans respond to these viral pathogens. Participants include Washington University’s Michael Diamond, a West Nile expert.